Valproic Acid

丙戊酸

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameValproic Acid
Drug Alias Name2-丙基戊酸acidum valproicum丙戊醯酸BacecaAvugane +[12
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsCNS Embryonal TumorBipolar I DisorderSolid tumours +[34
Global Approved IndicationsSeizures
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1978/02/28
Country/TerritoryBelgiumCanadaUnited States +[8
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPending
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesNorthwestern University
Active IndicationsBrain Injuries, Traumatic
Inactive IndicationsCNS Embryonal TumorBipolar I DisorderSolid tumours +[33

Other Information

ATC CodeN03AG01